Could CRISPR Therapeutics Stock Help You Retire a Millionaire?
The pandemic has brought a new awareness to genetic medicine and scientific research as a whole. Aside from the first authorized vaccine using messenger RNA (mRNA), the past 18 months has also seen a deluge of gene-editing companies go public and the first gene-editing therapy delivered directly inside a patient.
One of the pioneers of the technology is CRISPR Therapeutics (NASDAQ: CRSP). It's making its own news and positioned to be one of the leading companies in this new era of gene-based medicine. It's fascinating science and a win for humanity. But can the stock help you retire rich? It's one of my favorite companies in the space. But I think the amount of competition might stack the odds against it. Here's why.
Image source: Getty Images.
Source Fool.com
